Roche Holding Correlations

RHHBF Stock

USD 360.00 8.93 2.54%

The current 90-days correlation between Roche Holding AG and Novartis AG is 0.03 (i.e., Significant diversification). The correlation of Roche Holding is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Roche Holding Correlation With Market

Good diversification

The correlation between Roche Holding AG and DJI is -0.01 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Roche Holding AG and DJI in the same portfolio, assuming nothing else is changed.

The ability to find closely correlated positions to Roche Holding could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Roche Holding when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Roche Holding - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Roche Holding AG to buy it.

Moving together with Roche OTC Stock

0.79	JNJ	Johnson Johnson	Pair Corr
0.73	NVS	Novartis AG ADR	Pair Corr
0.68	NVSEF	Novartis AG	Pair Corr
0.73	WF	Woori Financial Group	Pair Corr
0.74	ADYYF	Adyen NV	Pair Corr
0.69	PDD	PDD Holdings	Pair Corr

Moving against Roche OTC Stock

0.49	MRK	Merck Company Aggressive Push	Pair Corr
0.61	MDAI	Spectral AI	Pair Corr
0.61	HSTC	HST Global	Pair Corr

Related Correlations Analysis

	NVSEF	AZNCF	RHHBY	SNY	RHHVF	GRFS	NVS	AZN	GSK	BAYRY
NVSEF		0.7	0.8	0.69	0.8	-0.41	0.89	0.75	0.76	0.0	NVSEF
AZNCF	0.7		0.88	0.83	0.87	-0.36	0.68	0.94	0.81	0.0	AZNCF
RHHBY	0.8	0.88		0.95	0.99	-0.44	0.79	0.94	0.84	0.0	RHHBY
SNY	0.69	0.83	0.95		0.94	-0.43	0.7	0.88	0.75	0.0	SNY
RHHVF	0.8	0.87	0.99	0.94		-0.43	0.77	0.93	0.83	0.0	RHHVF
GRFS	-0.41	-0.36	-0.44	-0.43	-0.43		-0.47	-0.3	-0.26	0.0	GRFS
NVS	0.89	0.68	0.79	0.7	0.77	-0.47		0.75	0.81	0.0	NVS
AZN	0.75	0.94	0.94	0.88	0.93	-0.3	0.75		0.9	0.0	AZN
GSK	0.76	0.81	0.84	0.75	0.83	-0.26	0.81	0.9		0.0	GSK
BAYRY	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		BAYRY
	NVSEF	AZNCF	RHHBY	SNY	RHHVF	GRFS	NVS	AZN	GSK	BAYRY

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

RHHVF	+ 0.99	RHHBY
SNY	+ 0.95	RHHBY
AZN	+ 0.94	AZNCF
AZN	+ 0.94	RHHBY
RHHVF	+ 0.94	SNY
AZN	+ 0.93	RHHVF

High negative correlations

NVS	- 0.47	GRFS
GRFS	- 0.44	RHHBY
GRFS	- 0.43	RHHVF
GRFS	- 0.43	SNY
GRFS	- 0.41	NVSEF
GRFS	- 0.36	AZNCF

Risk-Adjusted Indicators

There is a big difference between Roche OTC Stock performing well and Roche Holding OTC Stock doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Roche Holding's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
NVSEF	1.55	0.12	0.04	0.54	1.92	(2.17)	4.78	(4.01)	10.41
AZNCF	1.96	0.31	0.13	(2.06)	2.13	(2.22)	3.94	(3.49)	18.21
RHHBY	0.88	0.24	0.21	1.48	0.85	(0.98)	2.62	(1.92)	5.32
SNY	1.04	0.19	0.16	(1.11)	1.00	(1.34)	2.16	(1.82)	10.59
RHHVF	1.10	0.25	0.19	1.47	0.99	(1.21)	2.16	(1.75)	5.57
GRFS	2.41	(0.11)	0.00	(0.19)	0.00	0.00	5.81	(4.08)	14.79
NVS	0.88	0.09	0.08	0.24	0.99	(1.00)	1.90	(2.12)	6.69
AZN	0.98	0.28	0.22	1.74	1.03	(1.11)	2.04	(1.86)	5.90
GSK	1.20	0.22	0.17	0.42	1.09	(1.43)	3.45	(1.95)	11.70
BAYRY	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00

Be your own money manager

Our tools can tell you how much better you can do entering a position in Roche Holding without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Analyst Advice Now

Analyst Advice

Analyst recommendations and target price estimates broken down by several categories

All Next

Launch Module

Roche Holding Corporate Management

Elected by the shareholders, the Roche Holding's board of directors comprises two types of representatives: Roche Holding inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Roche. The board's role is to monitor Roche Holding's management team and ensure that shareholders' interests are well served. Roche Holding's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Roche Holding's outside directors are responsible for providing unbiased perspectives on the board's policies.

Barbara Schadler	Head Communications	Profile
Claudia Bockstiegel	G Counsel	Profile
Bruno Eschli	Head Relations	Profile
Johannes MD	Head Devel	Profile
Thomas Schinecker	Chief Diagnostics	Profile
Cristina Wilbur	Member of the Executive Committee, Head Group Human Resources	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC